The Food and Drug Administration (FDA), Nagpur, has issued a letter to the government, semi-government, and private doctors, hospitals, and health departments directing them to report cases of adverse drug reactions (ADR) observed in any patient. This step was taken to ensure early sampling, testing, and corrective measures regarding drug usage.

The drug regulatory authority has urged stakeholders to report ADR either to them or directly upload details on the website of the Indian Pharmacopoeia Commission (IPC) (IPC.gov.in).

This special initiative has been undertaken by the commission as a part of the 2nd National Pharmacovigilance Week, observed between September 17 and 23, 2022. The initiative has been introduced to raise awareness about ADR.

Dr Viraj Paunikar, Jr. commissioner of drugs, FDA, stated that the plan was conceptualized and implemented under the Pharmacovigilance Programme of India (PPI). According to the plan, senior officials like civil surgeons, district health officers, and so on have been approached to ensure the health infrastructure, facilities, and professionals working under them are sensitive about reporting ADR.

He further added that the objective of the exercise is to ensure that studies and research are carried out to ensure that medications and medical services are improved. 

(Source: https://thehealthmaster.com/2022/09/30/fda-to-doctors-hospitals-report-adverse-drug-reactions/ )